Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Marina F Kalashnikova"'
Autor:
Mikhail B. Antsiferov, Nikolay A. Demidov, Marina F. Kalashnikova, Olga V. Duhareva, Olga K. Vikulova, Marina V. Shestakova
Publikováno v:
Сахарный диабет, Vol 23, Iss 2, Pp 113-124 (2020)
BACKGROUND: State Register of Diabetes Mellitus (SRDM) plays an important role in the dynamic analysis of the epidemiological parameters that evaluate the disease itself and its complications, and also helps to analyze the quality of specialized medi
Externí odkaz:
https://doaj.org/article/aa0cc1c6ed4c40c3ab8d908ce68b3a5f
Publikováno v:
Сахарный диабет, Vol 21, Iss 1, Pp 5-14 (2018)
This review examined the current problem of low adherence to treatment in patients with chronic diseases, particularly type 2 diabetes mellitus. According to the definition of the World Health Organization, ‘adherence to treatment’ is the degree
Externí odkaz:
https://doaj.org/article/724422fd3dc147fc8691a8c50916964f
Autor:
Ivan I. Dedov, Marina F. Kalashnikova, Dmitriy Y. Belousov, Aleksey S. Kolbin, Vladimir V. Rafalskiy, Aleksey E. Cheberda, Mariya A. Kantemirova, Vadim D. Zakiev, Valentin V. Fadeyev
Publikováno v:
Сахарный диабет, Vol 20, Iss 6, Pp 403-419 (2017)
Background: Cost-of-Illness Analysis (COI) constitutes the basis for the decision-making process on the budget and allocation in a modern health care system. Considering the wide prevalence of type 2 diabetes mellitus (Т2DM), it is important to perf
Externí odkaz:
https://doaj.org/article/539c7cdef59a4e00acef6e429a6d993f
Autor:
Ivan I. Dedov, Marina F. Kalashnikova, Dmitriy Y. Belousov, Vladimir V. Rafalskiy, Victor Y. Kalashnikov, Aleksey S. Kolbin, Diana R. Yazykova, Leonid R. Ivanenko
Publikováno v:
Сахарный диабет, Vol 19, Iss 6, Pp 443-456 (2016)
Rationale. The rising incidence of type 2 diabetes mellitus (T2DM) allows researchers to conduct observational multicentre studies and obtain objective information about the epidemiology of diabetes and its complications and evaluate the efficacy of
Externí odkaz:
https://doaj.org/article/8f18372c0b1c4430beb7f951445b7466
Publikováno v:
Сахарный диабет, Vol 19, Iss 3, Pp 260-272 (2016)
Background. A pharmaco-epidemiological study comparing the dynamics of different anti-diabetic drugs in patients with type 2 diabetes mellitus (T2DM) in Russia was conducted using data from a diabetes registry.Objective. To assess and compare the fre
Externí odkaz:
https://doaj.org/article/09884a86f20b40cab8922856a4ed5ad9
Publikováno v:
Eur Thyroid J
Introduction: A number of classification systems (TIRADS) have been developed to estimate the likelihood of malignancy in thyroid nodules, but their reproducibility is yet to be assessed. We evaluated the interobserver variability and diagnostic perf
Autor:
Marina Vladimirovna Shestakova, Nikolay A. Demidov, Olga K. Vikulova, Olga V. Duhareva, Mikhail Borisovich Antsiferov, Marina F. Kalashnikova
Publikováno v:
Сахарный диабет, Vol 23, Iss 2, Pp 113-124 (2020)
BACKGROUND: State Register of Diabetes Mellitus (SRDM) plays an important role in the dynamic analysis of the epidemiological parameters that evaluate the disease itself and its complications, and also helps to analyze the quality of specialized medi
Publikováno v:
Сахарный диабет, Vol 21, Iss 1, Pp 5-14 (2018)
This review examined the current problem of low adherence to treatment in patients with chronic diseases, particularly type 2 diabetes mellitus. According to the definition of the World Health Organization, ‘adherence to treatment’ is the degree
Autor:
Leonid R. Ivanenko, Marina F. Kalashnikova, Aleksey S. Kolbin, Ivan Ivanovich Dedov, D Belousov, Diana R. Yazykova, Victor Yur'evich Kalashnikov, Vladimir Rafalskiy
Publikováno v:
Сахарный диабет, Vol 19, Iss 6, Pp 443-456 (2016)
Rationale. The rising incidence of type 2 diabetes mellitus (T2DM) allows researchers to conduct observational multicentre studies and obtain objective information about the epidemiology of diabetes and its complications and evaluate the efficacy of
Autor:
Jose Antônio Marin-Neto, Jeanne Clark, Alfredo Ramirez, Philip Böhme, Victor Gurevich, Miguel Urina, Valdis Pirags, Heather Lochnan, Jan Cornel, Bu Yeap, Ricardo Bohorquez, Marina F Kalashnikova, Aldo Pietro Maggioni, ALVARO AVEZUM, Igor Bondarenko, Monica Acevedo, Francesco Cacciatore, Weiping Jia, B. L. Gregoire Nyomba, Neslihan Bascil Tutuncu, Anastasia F Hutchinson, Sudeep K, Moti Kashyap, Adrian Vlad, Aivars Lejnieks, Jeong-Taek Woo, Shirley Jansen, Cristina Facanha, Laura Bryan, Louise Bordeleau, Patricio Lopez-Jaramillo, Adriana Forti, Flavia Lucia Lombardo, Malgorzata Sikora-Frac, Peter Colman, Olga Bulkina, ERNESTO GERMAN CARDONA MUÑOZ, Melanie Davies, JAIME CARMONA-HUERTA, Hertzel Gerstein, Jackie Bosch, Alina Babenko, Philip Aylward, Qifu Li, Yury Vasyuk, Asem Ali, Anna Novials, Andrzej Budaj, Anne Taylor
Publikováno v:
Diabetes Care. 39:709-716
OBJECTIVE The Outcome Reduction With Initial Glargine Intervention (ORIGIN) trial reported neutral effects of insulin glargine on cardiovascular outcomes and cancers and reduced incident diabetes in high–cardiovascular risk adults with dysglycemia